Acamprosate API Manufacturers

compare suppliers & get competitive offers

Filters

Reset

Selected filters:

Type
Production region
Qualifications
Country of origin

Located in:

India
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • coa

  • CEP

  • WC

  • DMF

  • GMP

  • FDA

Contact supplier

Replies slower than most

Located in:

India
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Acamprosate API 77337-76-9?

Description:
Here you will find a list of producers, manufacturers and traders of Acamprosate. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Acamprosate 
Synonyms:
Acamprosato , Acamprosatum , N-acetyl homotaurine , N-Acetylhomotaurine , Acamprosate calcium  
Cas Number:
77337-76-9 
DrugBank number:
DB00659 
Unique Ingredient Identifier:
N4K14YGM3J

About Acamprosate

More information about the use of: Acamprosate. Acamprosate, also known by the brand name Campral™, is a drug used for treating alcohol dependence. Acamprosate is thought to stabilize the chemical balance in the brain that would otherwise be disrupted by alcoholism, possibly by blocking glutaminergic N-methyl-D-aspartate receptors, while gamma-aminobutyric acid type A receptors are activated. Reports indicate that acamprosate only works with a combination of attending support groups and abstinence from alcohol.

Certain serious side effects include allergic reactions, irregular heartbeats, and low or high blood pressure, while less serious side effects include headaches, insomnia, and impotence. Acamprosate should not be taken by people with kidney problems or allergies to the drug.

You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.

Acamprosate is a type of Substances for alcohol addiction


Pharmaceutical API Subcategory: Substances for Alcohol AddictionSubstances for alcohol addiction are a vital subcategory within the pharmaceutical active pharmaceutical ingredients (APIs) market. These substances play a crucial role in the development of medications and therapies designed to address alcohol addiction, a prevalent and serious health issue worldwide.

APIs for alcohol addiction typically consist of specific chemical compounds that target the neurochemical pathways involved in addiction. These substances act on the central nervous system to modulate brain functions, reducing cravings and withdrawal symptoms associated with alcohol dependence.

Common API substances utilized in the treatment of alcohol addiction include naltrexone, acamprosate, and disulfiram. Naltrexone acts by blocking the brain's opioid receptors, thereby decreasing the pleasurable effects of alcohol consumption and reducing cravings. Acamprosate works by stabilizing the chemical balance in the brain, reducing the distressing symptoms experienced during alcohol withdrawal. Disulfiram, on the other hand, creates an unpleasant reaction when alcohol is consumed, acting as a deterrent for individuals trying to abstain from alcohol.

Pharmaceutical companies and research organizations are continuously exploring innovative API substances and formulations to improve the effectiveness and tolerability of alcohol addiction treatments. The development of new substances often involves rigorous clinical trials to ensure their safety and efficacy.

The market for substances targeting alcohol addiction is driven by the increasing awareness of the detrimental effects of excessive alcohol consumption and the growing demand for effective treatment options. By providing pharmaceutical APIs tailored to this subcategory, manufacturers contribute to combating alcohol addiction and supporting individuals on their journey towards recovery.


Acamprosate (Substances for alcohol addiction), classified under Anti-addiction agents


Anti-addiction agents are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment and management of various forms of addiction. These agents target the neurochemical pathways in the brain that are involved in addiction and dependence, offering therapeutic interventions to individuals struggling with substance abuse disorders.

One prominent group of anti-addiction agents includes opioid receptor antagonists, such as naltrexone and naloxone. These APIs bind to opioid receptors in the brain, blocking the euphoric effects of opioids and reducing cravings. By doing so, they help individuals overcome opioid addiction and prevent relapse.

Another essential class of anti-addiction agents are nicotine receptor agonists, like varenicline. These APIs target nicotine receptors in the brain, reducing the pleasurable sensations associated with smoking and alleviating nicotine withdrawal symptoms. This aids in smoking cessation efforts and enhances long-term abstinence rates.

Furthermore, anti-addiction agents may also encompass APIs used in the treatment of alcohol addiction, such as disulfiram and acamprosate. Disulfiram inhibits the breakdown of alcohol in the body, leading to unpleasant reactions when alcohol is consumed, thus discouraging its use. Acamprosate, on the other hand, helps normalize brain activity disrupted by chronic alcohol use, reducing cravings and promoting abstinence.

In conclusion, anti-addiction agents are a critical category of pharmaceutical APIs used to combat addiction and substance abuse disorders. By targeting specific neurochemical pathways, these agents provide valuable support in overcoming addiction, preventing relapse, and improving the overall well-being of individuals affected by substance abuse.



Acamprosate manufacturers | traders | suppliers

We have 2 companies offering Acamprosate produced in 1 different countries.

Get in contact with the supplier of your choice:

  • Ind-Swift Labs. from India, product country of origin India
  • Emcure Pharma from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.